mRNA delivery systems for cancer immunotherapy: lipid nanoparticles and beyond
ME Senti, LG Del Valle, RM Schiffelers - Advanced Drug Delivery Reviews, 2024 - Elsevier
Abstract mRNA-based vaccines are emerging as a promising alternative to standard cancer
treatments and the conventional vaccines. Moreover, the FDA-approval of three nucleic acid …
treatments and the conventional vaccines. Moreover, the FDA-approval of three nucleic acid …
mRNA melanoma vaccine revolution spurred by the COVID-19 pandemic
Z Xu, DE Fisher - Frontiers in immunology, 2023 - frontiersin.org
The advent of mRNA vaccines represents a significant advance in the field of vaccinology.
While several vaccine approaches (mRNA, DNA, recombinant protein, and viral-vectored …
While several vaccine approaches (mRNA, DNA, recombinant protein, and viral-vectored …
Current Status of Human Papillomavirus–Targeted Therapies Development in Head and Neck Cancer
JC Park, B Bertaux, J Park, S Park - JCO Precision Oncology, 2023 - ascopubs.org
PURPOSE While the incidence of smoking-related head and neck squamous cell carcinoma
(HNSCC) has been declining, that of human papillomavirus (HPV)–mediated HNSCC has …
(HNSCC) has been declining, that of human papillomavirus (HPV)–mediated HNSCC has …
[图书][B] Potential benefits and limitations of mRNA technology for vaccine research and development for infectious diseases and virus-induced cancers: report of the …
World Health Organization - 2023 - books.google.com
Page 1 Potential benefits and limitations of mRNA technology for vaccine research and
development for infectious diseases and virus-induced cancers 圓 + 000000 Report of the WHO …
development for infectious diseases and virus-induced cancers 圓 + 000000 Report of the WHO …